Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Effective treatments for severe alopecia areata are still lacking.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Hair grays due to oxidative stress and fewer functioning melanocytes.

Oxidative stress plays a significant role in vitiligo, and both skin and non-skin cells may be involved.